XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity (Tables)
3 Months Ended
Sep. 30, 2023
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended September 30, 

    

2022

    

2023

Cost of goods sold

$

216

$

232

Selling, general and administrative

6,840

6,731

Research and development

121

126

Stock-based compensation expense

$

7,177

$

7,089

Schedule of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2023

 

83,677

 

$

87.09

 

Granted

 

Exercised

 

(4,752)

88.39

Expired or forfeited

 

Outstanding at September 30, 2023

 

78,925

$

87.01

6.9 years

$

2,449

Exercisable at September 30, 2023

34,225

$

83.15

 

4.8 years

$

1,194

Summary of RSU award activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2023

 

455,515

$

85.15

Granted

 

307,506

93.35

Vested

 

(363,820)

79.00

Forfeited

 

(1,890)

74.15

Nonvested at September 30, 2023

 

397,311

$

97.19